Evidence map›Paper›PMID 25819030›Full record

ReviewCancer letters2015

Radiation takes its Toll.

Josephine A Ratikan, Ewa D Micewicz, Michael W Xie, Dörthe Schaue

Abstract readReview
In one paragraph

Review in Cancer letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. DAMPs and radiation injury.Frontiers in immunology · 2024
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Radiation-induced tissue damage and response.The Journal of pathology · 2020
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Josephine A RatikanDepartment of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, CA, USA.
Ewa D MicewiczDepartment of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, CA, USA.
Michael W XieDepartment of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, CA, USA.
Dörthe SchaueDepartment of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, CA, USA. Electronic address: dschaue@mednet.ucla.edu.

Funding

UCLA Center for Biological RadioprotectorsU19AI067769 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MCBRIDE, WILLIAM H. · 2005 to 2019
$44.6M
NIAID NIH HHS 2U19 AI067769NIAID NIH HHS U19 AI067769
6 · The paper itself

Abstract

The ability to recognize and respond to universal molecular patterns on invading microorganisms allows our immune system to stay on high alert, sensing danger to our self-integrity. Our own damaged cells and tissues in pathological situations activate similar warning systems as microbes. In this way, the body is able to mount a response that is appropriate to the danger. Toll-like receptors are at the heart of this pattern recognition system that initiates innate pro-oxidant, pro-inflammatory signaling cascades and ultimately bridges recognition of danger to adaptive immunity. The acute inflammatory lesions that are formed segue into resolution of inflammation, repair and healing or, more dysfunctionally, into chronic inflammation, autoimmunity, excessive tissue damage and carcinogenesis. Redox is at the nexus of this decision making process and is the point at which ionizing radiation initially intercepts to trigger similar responses to self-damage. In this review we discuss our current understanding of how radiation-damaged cells interact with Toll-like receptors and how the immune systems interprets these radiation-induced danger signals in the context of whole-body exposures and during local tumor irradiation.

Indexed as

HumansImmune SystemInflammationRadiation InjuriesReactive Oxygen SpeciesToll-Like ReceptorsReactive Oxygen SpeciesToll-Like ReceptorsInflammationRadiationReactive oxygen speciesRedoxToll-like receptors

Identifiers

PMID25819030
PMCPMC4578968

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.